Ad is loading...
FEKFX
Price
$16.47
Change
-$0.05 (-0.30%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

FEKFX vs VIVAX

Header iconFEKFX vs VIVAX Comparison
Open Charts FEKFX vs VIVAXBanner chart's image
Fidelity Equity-Income K6
Price$16.47
Change-$0.05 (-0.30%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
FEKFX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEKFX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEKFX is a StrongBuy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. FEKFX (216M). VIVAX pays higher dividends than FEKFX: VIVAX (2.25) vs FEKFX (1.80). FEKFX was incepted earlier than VIVAX: FEKFX (5 years) vs VIVAX (32 years). FEKFX is a more actively managed with annual turnover of: 36.00 vs. VIVAX (10.00). FEKFX has a lower initial minimum investment than VIVAX: FEKFX (0) vs VIVAX (3000). FEKFX annual gain was more profitable for investors over the last year : 27.30 vs. VIVAX (25.55). FEKFX return over 5 years is better than : 68.52 vs. VIVAX (50.81).
FEKFXVIVAXFEKFX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years32 years-
Gain YTD18.99317.912106%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets216M184B0%
Annual Yield % from dividends1.802.2580%
Returns for 1 year27.3025.55107%
Returns for 3 years24.3921.58113%
Returns for 5 years68.5250.81135%
Returns for 10 yearsN/A110.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHI22.300.74
+3.43%
PLDT
SPOT458.32-19.18
-4.02%
Spotify Technology SA
ADV3.10-0.14
-4.32%
Advantage Solutions
AMLX4.76-0.26
-5.18%
Amylyx Pharmaceuticals
ICAD1.64-0.14
-8.12%
iCAD